Long-term follow-up of myopic choroidal neovascularization treated with ranibizumab

Ophthalmologica

Volumn 227, Issue 1, 2011, Pages 39-44

  Franqueira, Nuno ^a   Cachulo, M Luz ^a,b   Pires, Isabel ^a,b   Fonseca, Pedro ^a,b   Marques, Inês ^a   Figueira, João ^a,b   Silva, Rufino ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

Anti VEGF; Choroidal neovascularization; Pathological myopia; Ranibizumab

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MYOPIA; MYOPIC SUBRETINAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; RETINA FOVEA; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84155170752     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000333213     Document Type: Article

References (25)

1. Soubrane G: Choroidal neovascularization in pathologic myopia: Recent developments in diagnosis and treatment. Surv Ophthalmol 2008; 53: 121-138. (Pubitemid 351381556)
2. Grossniklaus HE, Green WR: Pathologic findings in pathologic myopia. Retina 1992; 12: 127-133.
3. Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A, Tokoro T, Mochizuki M: Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003; 87: 570-573. (Pubitemid 36535327)
4. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ: Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103: 1241-1244. (Pubitemid 26282507)
5. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL: Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984; 91: 1573-1581. (Pubitemid 15197032)
6. Hampton GR, Kohen D, Bird AC: Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983; 90: 923-926. (Pubitemid 13004305)
7. Tabandeh H, Flynn HW Jr, Scott IU, Lewis ML, Rosenfeld PJ, Rodriguez F, Rodriguez A, Singerman LJ, Schiffman J: Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 1999; 106: 2063-2067. (Pubitemid 30194225)
8. Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M: Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groups. Ophthalmology 2002; 109: 712-719. (Pubitemid 34270128)
9. Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA, Verteporfin in Photodynamic Therapy Study Group: Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of a randomized clinical trial - VIP report No 3. Ophthalmology 2003; 110: 667-672.
10. Silva RM, Ruiz-Moreno JM, Nascimento J, Carneiro A, Rosa P, Barbosa A, Carvalheira F, Faria Abreu JR, Cunha-Vaz JG: Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina 2008; 28: 1117-1123.
11. Silva RM, Ruiz-Moreno JM, Rosa P, Carneiro A, Nascimento J, Rito LF, Cachulo ML, Carvalheira F, Murta JN: Intravitreal ranibizumab for myopic choroidal neovascularization: 12 months results. Retina 2010; 30: 407-417.
12. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group: Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444. (Pubitemid 44511558)
13. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group: Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431. (Pubitemid 44511557)
14. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS: Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006; 141: 456-462. (Pubitemid 43265948)
15. Monés JM, Amselem L, Serrano A, Garcia M, Hijano M: Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye 2009; 23: 1275-1280.
16. Lalloum F, Souied EH, Bastuji-Garin S, Puche N, Querques G, Glacet-Bernard A, Coscas G, Soubrane G, Leveziel N: Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina 2010; 30: 399-406.
17. Rosenfeld PJ, Rich RM, Lalwani GA: Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am 2006; 19: 361-372. (Pubitemid 44279358)
18. Lai TY, Chan WM, Liu DT, Lam DS: Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Retina 2009; 29:750-756.
19. Calvo-Gonzalez C, Reche-Futos J, Donate J, Fernandez-Perez C, Garcia-Feijoo J: Intravitreal ranibizumab for myopic choroidal neovascularization: Factors predictive of visual outcome and need for retreatment. Am J Ophthalmol 2011; 151: 529-534.
20. Geitzenauer W, Kiss CG, Durbin MK, Abunto MT, Callan TM, Stetson PF, Wieland MR, Bressler NM, Gregori G, Schmidt-Erfurth UM: Comparing retinal thickness measurements from Cirrus spectral domain-And Stratus time domain-optical coherence tomography. Retina 2010; 30: 596-606.
21. Durbin M, Abunto T, Chang M, Lujan B: Retinal measurements: Comparison between cirrus HD-OCT and stratus OCT. 2007. www. meditec.zeiss.com/ C125679E00525939/ContainerTitel/ CirrusOCT/$File/retinal-measurements. pdf. (accessed June 1, 2011).
22. Abedi G, Patal P, Doros G, Subramanian ML: Transitioning from stratus OCT to cirrus OCT: A comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects. Graefes Arch Clin Exp Ophthalmol 2011; 249: 1353-1357.
23. Montero JA, Ruiz-Moreno JM: Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003; 87: 173-176. (Pubitemid 36152743)
24. Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M: Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment. Am J Ophthalmol 2004; 138: 602-607. (Pubitemid 39420488)
25. Soubrane G, Coscas G: Choroidal neovascular membranes in degenerative myopia; in Ryan SJ, Ogden TE, Hinton DR, Schachat AP, Wilkinson CP (eds): Retina. St Louis, CV Mosby, 2006, vol 2: Medical Retina, pp 1115- 1133.